Sigma Planning Corp Eli Lilly & CO Transaction History

Sigma Planning Corp

  • $3.22 Billion
  • Q3 2024

A detailed history of Sigma Planning Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Sigma Planning Corp holds 18,721 shares of LLY stock, worth $14.9 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
18,721
Previous 18,723 0.01%
Holding current value
$14.9 Million
Previous $17 Million 2.16%
% of portfolio
0.51%
Previous 0.54%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$772.14 - $960.02 $1,544 - $1,920
-2 Reduced 0.01%
18,721 $16.6 Million
Q2 2024

Aug 05, 2024
SELL
$724.87 - $909.04 $1.37 Million - $1.72 Million
-1,888 Reduced 9.16%
18,723 $17 Million
Q1 2024

May 01, 2024
BUY
$592.2 - $792.28 $4.08 Million - $5.46 Million
6,896 Added 50.28%
20,611 $16 Million
Q4 2023

Feb 01, 2024
SELL
$525.19 - $619.13 $3.95 Million - $4.66 Million
-7,526 Reduced 35.43%
13,715 $7.99 Million
Q3 2023

Nov 06, 2023
SELL
$434.7 - $599.3 $762,463 - $1.05 Million
-1,754 Reduced 7.63%
21,241 $11.4 Million
Q2 2023

Aug 01, 2023
SELL
$350.74 - $468.98 $353,195 - $472,262
-1,007 Reduced 4.2%
22,995 $10.8 Million
Q1 2023

May 05, 2023
BUY
$310.63 - $364.82 $1.32 Million - $1.55 Million
4,262 Added 21.59%
24,002 $8.24 Million
Q4 2022

Jan 24, 2023
BUY
$321.55 - $374.67 $349,203 - $406,891
1,086 Added 5.82%
19,740 $0
Q3 2022

Nov 10, 2022
BUY
$296.48 - $337.87 $264,163 - $301,042
891 Added 5.02%
18,654 $6.03 Million
Q2 2022

Aug 11, 2022
BUY
$278.73 - $327.27 $505,058 - $593,013
1,812 Added 11.36%
17,763 $5.76 Million
Q1 2022

Apr 20, 2022
SELL
$234.69 - $291.66 $217,792 - $270,660
-928 Reduced 5.5%
15,951 $4.57 Million
Q4 2021

Feb 02, 2022
BUY
$224.85 - $279.04 $411,250 - $510,364
1,829 Added 12.15%
16,879 $4.66 Million
Q3 2021

Oct 28, 2021
SELL
$221.6 - $272.71 $77,116 - $94,903
-348 Reduced 2.26%
15,050 $3.48 Million
Q2 2021

Aug 13, 2021
SELL
$180.55 - $233.54 $107,427 - $138,956
-595 Reduced 3.72%
15,398 $3.53 Million
Q1 2021

May 06, 2021
BUY
$164.32 - $212.72 $160,869 - $208,252
979 Added 6.52%
15,993 $2.99 Million
Q4 2020

Feb 09, 2021
SELL
$130.46 - $172.63 $402,208 - $532,218
-3,083 Reduced 17.04%
15,014 $2.54 Million
Q3 2020

Nov 03, 2020
BUY
$146.22 - $169.13 $403,274 - $466,460
2,758 Added 17.98%
18,097 $2.68 Million
Q2 2020

Jul 31, 2020
BUY
$136.42 - $164.18 $86,626 - $104,254
635 Added 4.32%
15,339 $2.52 Million
Q1 2020

May 01, 2020
SELL
$119.05 - $147.35 $26,905 - $33,301
-226 Reduced 1.51%
14,704 $2.04 Million
Q4 2019

Feb 03, 2020
BUY
$106.92 - $132.43 $44,051 - $54,561
412 Added 2.84%
14,930 $1.96 Million
Q3 2019

Nov 01, 2019
SELL
$106.79 - $116.16 $178,446 - $194,103
-1,671 Reduced 10.32%
14,518 $1.62 Million
Q2 2019

Aug 01, 2019
SELL
$110.79 - $129.32 $94,614 - $110,439
-854 Reduced 5.01%
16,189 $1.79 Million
Q1 2019

May 01, 2019
BUY
$111.31 - $131.02 $129,453 - $152,376
1,163 Added 7.32%
17,043 $2.21 Million
Q4 2018

Jan 31, 2019
SELL
$105.9 - $118.64 $114,266 - $128,012
-1,079 Reduced 6.36%
15,880 $1.84 Million
Q3 2018

Nov 07, 2018
BUY
$85.86 - $107.31 $17,343 - $21,676
202 Added 1.21%
16,959 $1.82 Million
Q2 2018

Aug 02, 2018
SELL
$75.7 - $86.88 $39,439 - $45,264
-521 Reduced 3.02%
16,757 $1.43 Million
Q1 2018

May 11, 2018
BUY
$74.21 - $87.6 $22,708 - $26,805
306 Added 1.8%
17,278 $1.34 Million
Q4 2017

Feb 07, 2018
SELL
$81.94 - $87.89 $10,242 - $10,986
-125 Reduced 0.73%
16,972 $1.43 Million
Q3 2017

Nov 06, 2017
BUY
$77.07 - $85.54 $1.32 Million - $1.46 Million
17,097
17,097 $1.46 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email